Ivermectin/Pyrantel Chew. Dog 272Mcg/227Mg

Verify with FDA CVM →

1,397 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,397
Total Reports
10
Deaths Reported
70.0%
Death Rate

Active Ingredients

Ivermectin/Pyrantel Chew. Dog 272Mcg/227Mg

Administration Routes

OralUnknown

Species Affected

Dog 1,293
Unknown 104

Most Affected Breeds

Retriever - Labrador 404
Crossbred Canine/dog 167
Retriever - Golden 111
Unknown 104
Shepherd Dog - German 96
Boxer (German Boxer) 47
Dog (other) 35
Pit Bull 33
Dog (unknown) 27
Rottweiler 26

Most Reported Reactions

INEFFECTIVE, HEARTWORM LARVAE 709
Digestive tract disorder NOS 503
Cardiac disorder NOS 441
No sign 237
INEFFECTIVE, ASCARIDS NOS 232
Lack of efficacy (endoparasite) - hookworm 231
Lack of efficacy - NOS 122
Vomiting 69
Tablets, Abnormal 57
Diarrhoea 33
INEFFECTIVE, HEARTWORM ADULTS 28
Lethargy (see also Central nervous system depression in 'Neurological') 26

Outcome Breakdown

Outcome Unknown
749 (57.5%)
Recovered with Sequela
467 (35.8%)
Recovered/Normal
60 (4.6%)
Ongoing
17 (1.3%)
Died
6 (0.5%)
Euthanized
4 (0.3%)

Data Summary

Metric Value
Total adverse event reports 1,397
Reports involving death 10
Case-fatality rate (reported events) 70.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin/Pyrantel Chew. Dog 272Mcg/227Mg Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 1,397 adverse event reports referencing Ivermectin/Pyrantel Chew. Dog 272Mcg/227Mg, including 10 reports in which the animal died — a 70.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin/Pyrantel Chew. Dog 272Mcg/227Mg. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin/Pyrantel Chew. Dog 272Mcg/227Mg reports are Dog (1,293 reports), Unknown (104 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (404), Crossbred Canine/dog (167), Retriever - Golden (111) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin/Pyrantel Chew. Dog 272Mcg/227Mg are INEFFECTIVE, HEARTWORM LARVAE (709), Digestive tract disorder NOS (503), Cardiac disorder NOS (441), No sign (237). Of the 1,303 reports with a coded outcome, Outcome Unknown is the leading category at 57.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin/Pyrantel Chew. Dog 272Mcg/227Mg.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial